ENTITY
Daewoong Pharmaceutical Co

Daewoong Pharmaceutical Co (069620 KS)

69
Analysis
Health Care • South Korea
Daewoong Pharmaceutical Co., Ltd. develops various kinds of medical drugs and vitamin supplements. The Company's medical drugs are used in areas, such as cardiology, dermatology, anti-biotic, and many other medical areas. Dae Woong's over-the-counter products include smoking deterrents, vitamins, and minerals.
more
bullish•HK inno.N
•05 Jul 2021 18:45

HK Inno.N IPO Valuation Analysis

Our base case valuation  of HK Inno.N is 75,534 won per share, which represents a 28% upside from the high end of the IPO price range. We have a...

Logo
399 Views
Share
bullish•HK inno.N
•02 Jul 2021 00:51

HK Inno.N IPO Preview

HK Inno.N is getting ready for an IPO in the Korean stock market. The IPO price range is from 50,000 won to 59,000 won. The IPO deal size is from...

Logo
563 Views
Share
bearish•Hugel Inc
•29 Jun 2020 18:11

Hugel Placement: A 5.2% Block Deal Sale

After the market close today, it was reported that BK Medical Group’s Chairman Dr. Kim Byung-Gun and Dr. BK Corp will sell their 5.2% stake...

Logo
591 Views
Share
•23 Apr 2020 17:05

StubWorld: Iljin, Alliance Global, H2O/Toho, Daewoong, Silicon Integrated/United Micro, Ayala

This week in StubWorld ... A change of pace with RV bifurcations having settled down (somewhat) from a month ago: a quick read through on three...

Logo
578 Views
Share
•28 Mar 2019 07:36

Daewoong: Entering "Botox World"

Daewoong Pharmaceutical Co (069620 KS) has traded up over the past year in anticipation of the launch of its botulinum toxin product Jeuveau in the...

Share
x